Showing results (881-890 of 1,095) with videos related to

Sort By:
Pageof 110
European Journal of Heart Failure|October 23, 2025
Global Registries and Surveys Programme-Heart Failure (GRASP-HF): Rationale, study design and research implicationsOvidiu Chioncel, Gianluigi Savarese, Cecile Laroche, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|April 15, 2025
Artificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of PrecisionDoosup Shin, Zainab Sami, Matthew Cannata, et al.
Nefrologia|April 29, 2018
Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerationsJordi Bover, Pablo Ureña-Torres, Josep-Vicent Torregrosa, et al.
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[Secondary atrial tricuspid regurgitation: an underestimated but increasingly clinically relevant valve disorder]Luigi P Badano, Michele Tomaselli, Chiara Fraccaro, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 3, 2001
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS studyM Lunt, P Masaryk, C Scheidt-Nave, et al.
Psychiatry Research|June 28, 2016
An international perspective on Facebook intrusionAgata Błachnio, Aneta Przepiorka, Martina Benvenuti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcificationNatalia Carrillo-López, Laura Martínez-Arias, Cristina Alonso-Montes, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?G Marcucci, E Biver, J J Body, et al.
Pageof 110